Graphs were prepared using GraphPad Prism version 9.1.2. Results Study population We screened 537 T2D individuals treated with GLP-1 RA or SGLT-2i, who underwent PCI for their first STEMI or NSTEMI. Of these, 443 completed the 24 months follow-up (Fig. 1). At admission, 265 patients ...
The American and European Societies of Cardiology have recently issued updated guidelines for the management of ST-elevation myocardial infarction (STEMI) and non-STEMI/unstable angina (NSTEMI/UA). The distinction between these two clinical manifestations of acute coronary syndrome (ACS) was first ...
Patients with Type 2 Diabetes Mellitus are increasingly susceptible to atherosclerotic plaque vulnerability, leading to severe cardiovascular events. In this study, we demonstrate that elevated serum levels of palmitic acid, a type of saturated fatty acid, are significantly linked to this enhanced vulnera...
A large proportion of patients presenting with STEMI or NSTEMI have CKD. Further efforts to address treatment gaps in the management of MI in the presence of CKD are needed to improve outcomes in this high-risk population. Table-... CS Fox,P Muntner,AY Chen,... - 《Circulation》 被引量...
Guidelines Drugs & Diseases Global Coverage Additional Resources Recommended Reading news Do Frail NSTEMI Patients Benefit From an Invasive Approach? news A Patient-First Approach May Improve Care in Type 2 Diabetes news Switching From IV to Oral Antibiotics Safe for Patients, Study Shows Advances ...
≥2 mm in men ≥40 years or ≥1.5 mm in women in leads V2–V3 and/or 1 mm in the other leads. Non-ST-segment myocardial infarction (NSTEMI) was defined as the presence of an acute coronary syndrome with a troponin I increase above the 99th percentile of a healthy reference population...
图2 复杂PCI器械保护性策略流程图 SBP为收缩压,ECG为心电图,STEMI为ST段抬高型心肌梗死,NSTEMI为非ST段抬高型心肌梗死,PA为肺动脉压,CO为心输出量,COP为心脏功率输出,PCWP为肺毛细血管楔压,CI为心脏指数,SvO2为静脉血氧饱和度,PCI为经皮冠状动脉介入治疗 四、Impella国际注册研究 cVAD注册研究 [ 17 ]是一项...
4.2.2 II a类 对于UA/NSTEMI后的低危患者 (即左心室功能正常,已经施行血管重建治疗和没 有高危特征)没有绝对禁忌证时,可以给予13受 体阻断剂(证据级别:B). 4.3肾素一血管紧张素一醛固酮系统抑制剂 4.3.1 I类①对于UA/NSTEMI后的患者有心 力衰竭,左心室功能不全(左室射血分数< 0.40),高血压或糖尿病,...
建议4:临床ACS患者,若心电图没有出现心肌损伤的变化,但cTn(包括hs-cTn)异常增高,结合病史可考虑NSTEMI诊断,应给予必要的临床干预治疗。 建议5:临床疑似ACS患者,若心电图没有出现心肌损伤的变化,cTn(包括hs-cTn)的检测结果未见明显异常,或hs-cTn略高于参考范围上限,可间隔1～3 h再次检测cTn(包括hs-cTn),观察cT...
对 UA/NSTEMI 的抗凝治疗并未 做新型抗凝药物的推荐 .[30] 3.6 急性冠状动脉综合征(ACS)的二级预防 2011 年 5 月的 RE-DEEM 研究声明因Ⅲ期 试验未能筛选出合适的剂量而使达比加群酯用 于 ACS 的二级预防试验最终搁浅.2011 年 8 月的 APPRAISE 2 研究中,阿哌沙班因出血风险大 于获益, 使试验提前终止....